A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
Introduction: Pregnancy is widely accepted as a period when relapses of multiple sclerosis (MS) are decreased, with an increased risk of relapse in the first months postpartum. This systematic review evaluated relapses during pregnancy and postpartum, according to disease-modifying therapy (DMT) exp...
Enregistré dans:
Auteurs principaux: | Kerstin Hellwig, Elisabetta Verdun di Cantogno, Meritxell Sabidó |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SAGE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b7d6f9d4b983426f9486c0cb22ee7040 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
par: Lugaresi A, et autres
Publié: (2013) -
The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
par: Sandra Thiel, et autres
Publié: (2021) -
Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
par: Dubey D, et autres
Publié: (2015) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
par: Fabricio González-Andrade, et autres
Publié: (2010) -
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
par: Julie A Murphy, et autres
Publié: (2010)